NeoGenomics Inc (NEO)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -87,968 | -144,250 | -8,347 | 4,172 | 8,006 |
| Revenue | US$ in thousands | 601,638 | 508,222 | 479,247 | 436,029 | 404,099 |
| Net profit margin | -14.62% | -28.38% | -1.74% | 0.96% | 1.98% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-87,968K ÷ $601,638K
= -14.62%
Neogenomics Inc.'s net profit margin has shown fluctuating trends over the past five years. In 2019, the company had a net profit margin of 1.96%, which gradually decreased to 0.94% in 2020. However, a significant decline was observed in 2021 when the net profit margin fell to -1.72%. This negative trend continued into 2022 with a further decrease to -28.30%. By the end of 2023, there was a slight improvement as the net profit margin stood at -14.87%.
Overall, the negative net profit margins in recent years indicate that Neogenomics Inc. has faced challenges in generating profits relative to its revenue. The company may need to focus on cost control, operational efficiency, and strategic planning to improve its profitability in the future.